Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 81

Adult ID

Global ID

HIV-STD-TB

Pediatric ID

Trainee

Transplant

COVID
Interactive Session

05 - Diagnostic Clinical Cases

Thursday, September 30, 2021
11:00 AM - 12:15 PM EDT

    Interactive Moderator(s)

  • James Dunn, PhD

    Director, Medical Microbiology and Virology
    Texas Children's Hospital
    Houston, TX, United States

    Cepheid (Individual(s) Involved: Self): Speakers' bureau; ChromaCode Inc. (Individual(s) Involved: Self): Scientific Research Study Investigator; Diasorin Molecular (Individual(s) Involved: Self): Scientific Research Study Investigator

  • Esther Babady, PhD

    Chief, Clinical Microbiology Service
    Laboratory Medicine
    Memorial Sloan Kettering
    New York, NY, United States

    Arc Bio (Individual(s) Involved: Self): Board Member; Copan (Individual(s) Involved: Self): Grant/Research Support; GenMark (Individual(s) Involved: Self): Grant/Research Support; Roche (Individual(s) Involved: Self): Advisor or Review Panel member

    • Panelist(s)

  • FL

    Francesca Lee, MD

    Associate Professor
    Department of Pathology and Medicine, Division of Infectious Diseases and Geographic Medicine
    University of Texas Southwestern
    Dallas, TX, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • CD

    Christopher Doern, PhD

    Director, Clinical Microbiology
    Virginia Commonwealth University Health System
    Richmond, VA, United States

    GeneCapture (Individual(s) Involved: Self): Consultant; Quidel: Consultant, Consultant, Consultant; Quidel (Individual(s) Involved: Self): Consultant

  • Colleen Kraft, MD, MSc

    Associate Professor
    Emory University
    Atlanta, GA, United States

    Rebiotix (Individual(s) Involved: Self): Advisor or Review Panel member

  • Samuel Dominguez, MD, PhD

    Professor
    Pediatric Infecitous Disease
    University of Colorado, School of Medicine
    Aurora, CO, United States

    BioFire (Individual(s) Involved: Self): Consultant, Research Grant or Support; DiaSorin Molecular (Individual(s) Involved: Self): Consultant; Pfizer (Individual(s) Involved: Self): Grant/Research Support

Participants should be aware of the following financial/non-financial relationships:
James Dunn, PhD: Cepheid (Individual(s) Involved: Self): Speakers' bureau; ChromaCode Inc. (Individual(s) Involved: Self): Scientific Research Study Investigator; Diasorin Molecular (Individual(s) Involved: Self): Scientific Research Study Investigator
Esther Babady, PhD: Arc Bio (Individual(s) Involved: Self): Board Member; Copan (Individual(s) Involved: Self): Grant/Research Support; GenMark (Individual(s) Involved: Self): Grant/Research Support; Roche (Individual(s) Involved: Self): Advisor or Review Panel member
Francesca Lee, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Christopher Doern, PhD: GeneCapture (Individual(s) Involved: Self): Consultant; Quidel: Consultant, Consultant, Consultant; Quidel (Individual(s) Involved: Self): Consultant
Colleen S. Kraft, MD, MSc: Rebiotix (Individual(s) Involved: Self): Advisor or Review Panel member
Samuel R. Dominguez, MD, PhD: BioFire (Individual(s) Involved: Self): Consultant, Research Grant or Support; DiaSorin Molecular (Individual(s) Involved: Self): Consultant; Pfizer (Individual(s) Involved: Self): Grant/Research Support

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE credits

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • explain the approach to diagnosing infectious illness in complex patients
  • discuss the role of the Clinical Microbiology Laboratory in the work up of patients with infectious illness
  • list new approaches to infectious disease diagnostics